Skip to content

X1-FFR 991

by Spectrawave, Inc.

X1-FFR 991 is a medical device (FDA Class II) made by Spectrawave, Inc., cleared under FDA 510(k) K251355 on 17 Oct 2025 and listed in FDA GUDID since 7 May 2026 (UDI-DI 00860008045539), active as of 2 Nov 2026.

Active United States. Also listed in GUDID (US).

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 2 Nov 2026

Documents

510(k) K251355

FDA submission, from GUDID

Trust

Unverified

Source GUDID, synced 2 Nov 2026.

Regulatory status

as of registry sync 2 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing Number00860008045539 UDI-DI Date7 May 2026ListedStatusListed GUDID: in commercial distribution
United StatesFDA 510(k)SESE from GUDID Substantially Equivalent · Traditional NumberK251355 Date17 Oct 2025DecidedStatusActive

Official records

From the FDA record

Device description
The SpectraWAVE X1-FFR Software is a standalone medical device which is used in the catheterization lab as an angiography image assessment tool for assessing Fractional Flow Reserve using non-invasive quantitative and functional analysis of coronary vasculature. The SpectraWAVE X1-FFR software comprises image processing and computational algorithms to perform functional coronary angiography, providing longitudinal estimations of coronary pressure drop and Fractional Flow Reserve (FFR) during angiogram and percutaneous coronary intervention (PCI) procedures. The SpectraWAVE X1-FFR Software is a procedural aid intended to be used to support diagnosis by clinicians. AI-derived algorithms are deployed on the device to support vessel segmentation and contouring. Analytical (non-AI) models are used for generating FFR values. The SpectraWAVE X1-FFR Software • provides measurements of localized coronary pressure drops over the length of a coronary vessel, including the right and left coronary tree. • provides dimensions of the coronary vessels and the amount of stenosis in coronary vessels; • enables physiology assessment in a non-invasive manner, without the need for adenosine and without the need for additional radiation and contrast administration.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 2 Nov 2026, as the labeller entered it.

Across registries

2 registries list this device

  • FDA 510(k) K251355 decided 17 Oct 2025 Active
  • FDA GUDID UDI-DI 00860008045539 listed 7 May 2026 Listed

Timeline

2 dated events

  1. Cleared FDA 510(k) K251355
  2. Listed FDA GUDID 00860008045539

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

GUDID

Trade name
X1-Ffr
Generic name
Diagnostic x-ray digital imaging system workstation
Model / reference
991
Primary DI / UDI-DI
00860008045539
FDA product code
QHA, LLZ
GMDN term
Diagnostic x-ray digital imaging system workstation
Device class
Class II
Regulation number
892.1600, 892.2050
GUDID distribution status
In Commercial Distribution

Similar devices

Other devices filed under FDA product code QHA (X-Ray Angiographic Imaging Based Coronary Vascular Simulation Software Device).

Other devices from Spectrawave, Inc.

See all devices from Spectrawave, Inc. →

Properties

  • Prescription use
  • Serial number
Other properties (13, all answered No)